Means Investment Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $885K | Buy |
2,444
+17
| +0.7% | +$5.82K | 0.07% | 98 |
|
|
2026
Q1 | $854K | Buy |
2,427
+104
| +4% | +$37.1K | 0.07% | 96 |
|
|
2025
Q4 | $760K | Buy |
2,323
+14
| +0.6% | +$4.44K | 0.06% | 102 |
|
|
2025
Q3 | $652K | Buy |
2,309
+14
| +0.6% | +$4.06K | 0.06% | 111 |
|
|
2025
Q2 | $641K | Sell |
2,295
-42
| -2% | -$11.9K | 0.06% | 111 |
|
|
2025
Q1 | $728K | Sell |
2,337
-22
| -0.9% | -$6.5K | 0.08% | 105 |
|
|
2024
Q4 | $615K | Buy |
2,359
+8
| +0.3% | +$2.37K | 0.06% | 116 |
|
|
2024
Q3 | $758K | Buy |
2,351
+12
| +0.5% | +$3.92K | 0.08% | 105 |
|
|
2024
Q2 | $731K | Buy |
2,339
+12
| +0.5% | +$3.52K | 0.09% | 101 |
|
|
2024
Q1 | $662K | Sell |
2,327
-76
| -3% | -$22.2K | 0.09% | 112 |
|
|
2023
Q4 | $692K | Buy |
2,403
+1
| +0% | +$272 | 0.1% | 110 |
|
|
2023
Q3 | $646K | Buy |
2,402
+15
| +0.6% | +$3.74K | 0.11% | 109 |
|
|
2023
Q2 | $530K | Buy |
2,387
+3
| +0.1% | +$696 | 0.08% | 118 |
|
|
2023
Q1 | $576K | Sell |
2,384
-27
| -1% | -$6.63K | 0.1% | 110 |
|
|
2022
Q4 | $633K | Buy |
2,411
+16
| +0.7% | +$4.29K | 0.13% | 104 |
|
|
2022
Q3 | $540K | Sell |
2,395
-36
| -1% | -$8.73K | 0.12% | 106 |
|
|
2022
Q2 | $591K | Buy |
2,431
+17
| +0.7% | +$4.17K | 0.13% | 102 |
|
|
2022
Q1 | $584K | Buy |
2,414
+6
| +0.2% | +$1.38K | 0.11% | 107 |
|
|
2021
Q4 | $542K | Buy |
2,408
+3
| +0.1% | +$633 | 0.1% | 111 |
|
|
2021
Q3 | $511K | Buy |
2,405
+104
| +5% | +$23.9K | 0.1% | 108 |
|
|
2021
Q2 | $561K | Buy |
2,301
+12
| +0.5% | +$2.95K | 0.11% | 106 |
|
|
2021
Q1 | $569K | Sell |
2,289
-39
| -2% | -$9.31K | 0.13% | 98 |
|
|
2020
Q4 | $547K | Buy |
2,328
+265
| +13% | +$61.1K | 0.12% | 96 |
|
|
2020
Q3 | $478K | Buy |
2,063
+48
| +2% | +$11.9K | 0.13% | 94 |
|
|
2020
Q2 | $473K | Buy |
2,015
+33
| +2% | +$7.53K | 0.15% | 89 |
|
|
2020
Q1 | $455K | Buy |
1,982
+30
| +2% | +$6.55K | 0.18% | 78 |
|
|
2019
Q4 | $471K | Buy |
1,952
+27
| +1% | +$5.95K | 0.16% | 84 |
|
|
2019
Q3 | $413K | Buy |
1,925
+21
| +1% | +$4.03K | 0.16% | 93 |
|
|
2019
Q2 | $346K | Sell |
1,904
-28
| -1% | -$5.01K | 0.14% | 103 |
|
|
2019
Q1 | $367K | Sell |
1,932
-50
| -3% | -$9.55K | 0.16% | 101 |
|
|
2018
Q4 | $386K | Buy |
+1,982
| New | +$387K | 0.21% | 82 |
|
Other funds holding AMGN
Means Investment Company's AMGN Position: Q2 2026 in Review
Means Investment Company increased its Amgen (AMGN) stake by 0.7% in Q2 2026, buying an estimated $5.82K and bringing the position to 2,444 shares worth $885K. The position accounts for 0.07% of the portfolio, ranked #98.
Means Investment Company first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Means Investment Company held 2,444 shares of Amgen worth $885K as of Q2 2026.
- Means Investment Company bought 17 Amgen shares in Q2 2026, an estimated $5.82K.
- Amgen made up 0.07% of Means Investment Company's portfolio in Q2 2026, its #98 holding.
- Means Investment Company first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.